CodeMap® Compliance Briefing: March 11, 2020
Editor's Welcome: In recent weeks, media reports have been dominated by the global spread and impact of the Coronavirus disease (COVID-19). These reports include news about the development and distribution of clinical laboratory tests to detect the virus. The FDA and CMS have been active in making COVID-19 testing available throughout the country. The FDA has issued instructions to laboratories for how to test for the virus under their Emergency Use Authorization (EUA) and CMS has created two new HCPCS codes for use in billing COVID-19 tests. Today's CodeMap® Compliance Briefing will explore these developments in greater detail. Next week, we will discuss associated diagnosis codes. As always, please forward any questions, comments, or suggestions to us via email.
Sorry, access to this content requires a current subscription.
Click here for publications catalog.
CPT copyright 2021 American Medical Association. All rights reserved.
* The responsibility for the content of any "National Correct Coding Policy" included in this product is with the Centers for Medicare and Medicaid
Services and no endorsement by the AMA is intended or should be implied. The AMA disclaims responsibility for any consequences or liability attributable to or related
to any use, nonuse, or interpretation of information contained in this product.